UBS Group’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,600
Closed -$1K 6999
2016
Q4
$1K Buy
+5,600
New +$1K ﹤0.01% 6681